Integrating New Therapies for Systemic Sclerosis–Associated Lung Fibrosis in Clinical Practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Integrating New Therapies for Systemic Sclerosis-Associated Lung Fibrosis in Clinical Practice
Lancet Respir Med 2021 May 17;[EPub Ahead of Print], D Khanna, CP DentonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.